Researchers engineer pancreatic cell transplants to evade immune response

January 05, 2009

Discovery moves diabetes type 1 cure closer to clinical application

In a finding that could significantly influence the way type 1 diabetes is treated, researchers at Albert Einstein College of Medicine of Yeshiva University have developed a technique for transplanting insulin-producing pancreatic cells that causes only a minimal immune response in recipients.

At present, cell transplantation therapy is limited because transplant recipients are forced to take powerful immunosuppressant medications that have toxic side effects and raise the risk of infection. This advance in mice, described in the online version of Gene Therapy, could pave the way for routine use of cell transplants as a therapy for type 1 diabetes in humans.

Type 1 diabetes is an incurable autoimmune disease in which the immune system mistakenly destroys the body's own pancreatic beta cells. Beta cells produce insulin, which breaks down sugar, or glucose, for use by the body. Without these cells, too much glucose builds up in the blood. High blood glucose levels damage cells and can eventually lead to complications such as heart disease, kidney disease, blindness, and premature death.

Type 1 diabetes affects up to 2.4 million Americans and can develop at any age, though it typically appears during childhood or adolescence. People with type 1 diabetes must closely monitor their blood glucose levels and take daily insulin injections for life.

A promising alternative to insulin injections is cellular transplantation, in which beta cells are harvested from cadavers and injected into the bloodstream of patients with diabetes; the new cells replace the recipients' destroyed pancreatic beta cells. Although such transplants can control type 1 diabetes, recipients must take immunosuppressant medications in order to prevent rejection of these beta foreign cells. "Ultimately, even with immunosuppressive therapy, most of these individuals end up rejecting the transplanted cells," says the study's principal investigator, Harris Goldstein, M.D., professor of pediatrics and of microbiology & immunology at Einstein.

In this study, Dr. Goldstein and his colleagues devised a way to make foreign beta cells invisible to a transplant recipient's immune system, dramatically protecting them from rejection. They did so by harnessing the innate ability of adenoviruses to evade the body's immune surveillance system. (Adenoviruses infect tissues that line the respiratory tract, eyes, intestines, and urinary tract). After infecting cells, adenoviruses produce proteins that prevent the cells from signaling the immune system that they have been infected and should be destroyed. The viruses also produce proteins that can turn off a cell's built-in self-destruct mechanism, which is usually triggered when something disturbs a cell's internal functions.

The researchers began with a special line of insulin-producing beta cells, developed at Einstein, that were harvested from mice. When injected into diabetic mice, these foreign cells can restore normal glucose control, but only temporarily. The transplanted cells are soon destroyed by the mouse's immune system and glucose levels begin to rise, returning to pre-transplant disease levels.

Dr. Goldstein and his colleagues genetically engineered these beta cells to include three adenoviral genes responsible for making immunosuppressive proteins. Diabetic mice that received these engineered foreign beta cells maintained normal glucose control for up to three months. In contrast, a control group of diabetic mice that received the regular foreign beta cells exhibited normal glucose control for just a few days.

"Clearly, the three proteins were not optimal, because ultimately the cells did get rejected," says Dr. Goldstein. "We are now looking at other viral genes that also contribute to immune suppression and are trying to identify the best gene combination to use."

Dr. Goldstein views the current experiment as a proof of concept. "We were able to demonstrate that genetically engineered beta cells can be made highly resistant to rejection and can basically correct diabetes. This technique could conceivably be applied to protect any type of cellular transplant from rejection."

However, pancreatic cell transplantation could not help treat patients with type 2 diabetes. In this form of the disease, patients have fully functional beta cells but cells throughout their body become resistant to insulin.

Albert Einstein College of Medicine

Biophysics of the Pancreatic B-Cell (NATO Asi Series) (Vol 211)
by Illani Atwater (Author), Eduardo Rojas (Author), Bernat Soria (Author)

Pancreatic Beta Cell in Health and Disease
by Susumu Seino (Editor), Graeme I. Bell (Editor)

The beta cells of the pancreatic islets of Langerhans are the only cells in the body that produce and secrete insulin. This metabolic hormone plays a central role in the maintenance of glucose homeostasis. This book provides a comprehensive review of the beta cell in health and disease. The book’s primary aim is to encourage investigators to become actively involved in diabetes research and the search for new approaches to prevent and treat diabetes.

Islet Transplantation and Beta Cell Replacement Therapy
by A.M. James Shapiro (Editor), James A.M. Shaw (Editor)

Beta cell replacement through transplantation remains the only treatment option for Type 1 diabetes enabling restoration of near-physiological glucose levels without significant hypoglycemia. Outlining the most recent advances and research breakthroughs, this practical guide and reference work explores the impact of islet cell transplantation and brings together leading multidisciplinary proponents critical to future success in the field. Edited by a surgeon and an endocrinologist at the forefront of the technology, this volume considers challenges associated with this procedure including lack of sufficient donor organs and the side effects of immunosuppressive therapy, as well as the potential benefits for current and future patients.

Beta Cells: Functions, Pathology and Research (Cell Biology Research Progress)
by Sarah E. Gallagher (Editor)

Beta cells or ss-cells, are a type of cell in the pancreas in areas called the islets of Langerhans. They make up 65-80 percent of the cells in the islets. Pancreatic B-cell is the only cell type that produces insulin to regulate glucose metabolism in the body. The insufficiency of insulin-producing B-cells results in dysregulation of blood glucose control, termed as type 1 diabetes. This book presents current research from across the globe in the study of Beta-cells, including the induction of pancreatic cancer cell death by elevated concentrations of extracellular zinc; the role of Rab GTPases and their effectors in the insulin secretory pathway of the pancreatic beta cell; In vivo reprogramming of pancreatic A-cells into B-like cells; and the role of glucocortoids, exercise and...

Beta-cell: Webster's Timeline History, 1955 - 2007
by Icon Group International (Author)

Webster's bibliographic and event-based timelines are comprehensive in scope, covering virtually all topics, geographic locations and people. They do so from a linguistic point of view, and in the case of this book, the focus is on "Beta-cell," including when used in literature (e.g. all authors that might have Beta-cell in their name). As such, this book represents the largest compilation of timeline events associated with Beta-cell when it is used in proper noun form. Webster's timelines cover bibliographic citations, patented inventions, as well as non-conventional and alternative meanings which capture ambiguities in usage. These furthermore cover all parts of speech (possessive, institutional usage, geographic usage) and contexts, including pop culture, the arts, social sciences...

Pancreatic beta cell culture: Proceedings of the fifth workshop conference Hoechst, Kitzbuhel, 5-9 October 1976 (International congress series)
by sole distributors for the USA, Elsevier North-Holland (Publisher)

Perspectives on the Molecular Biology and Immunology of the Pancreatic B Cell (Current Communications in Cell and Molecular Biology)
by Douglas Hanahan (Author), Hugh O. McDevitt (Author), George F. Cahill (Editor)

Antibiotic Inhibitors of Bacterial Cell Wall Biosynthesis
by Donald J. Tipper (Author)

Since the advent of antibiotic drugs, epidemic bacterial infections have ceased to be a scourge on mankind. This volume presents an overview of the field of antibiotic action. It also includes descriptions of the major mechanisms of resistance that are increasingly becoming a serious problem in dealing with bacterial infections. In detailing the precise mechanisms of action and resistance, allied to the rational application of modern organic chemistry, this information should highlight better structures for classical antibiotics, as well as other areas of bacterial metabolism that may be sensitive to chemotherapy. In such a multidisciplinary field, this accumulation of knowledge should be invaluable to all those working on better antibiotics.

FCT Cuts Costs of Cells in Beta Units.(Fuel Cell Technologies): An article from: Fuel Cell Technology News
by Gale Reference Team (Author)

This digital document is an article from Fuel Cell Technology News, published by Thomson Gale on December 1, 2004. The length of the article is 590 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: FCT Cuts Costs of Cells in Beta Units.(Fuel Cell Technologies)
Author: Gale Reference Team
Publication: Fuel Cell Technology News (Newsletter)
Date: December 1, 2004
Publisher: Thomson Gale
Volume: 7 Issue: 3 Page: NA

Distributed by Thomson...

Pancreatic beta cell agenesis: An entry from Thomson Gale's Gale Encyclopedia of Genetic Disorders, 2nd ed.
by Toni, MS, CGC Pollin (Author)

Information on many genetic disorders, and the frequent new findings on them, has been extremely difficult to come by—until now. The “Gale Encyclopedia of Genetic Disorders” addresses the need for current, hard-to-find facts on emerging discoveries. The two-volume Encyclopedia, presented in a single alphabetical sequence, provides clear, complete information on genetic disorders, including conditions, tests, procedures, treatments and therapies, in articles that are both comprehensive and easy to understand, in language accessible to laypersons. The articles are arranged in a standardized format for quick comparison and ease of use, while non-disorder topics are covered in detail with extended entries. Students will want to consult the “Gale Encyclopedia of Genetic Disorders”...